A novel leptin antagonist peptide inhibits breast cancer growth in vitro and in vivo

Publisher： John Wiley & Sons Inc

E-ISSN： 1582-4934|19|5|1122-1132

ISSN： 1582-1838

Source： Journal of Cellular and Molecular Medicine, Vol.19, Iss.5, 2015-05, pp. : 1122-1132

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy

By  

Journal of Cellular and Molecular Medicine, Vol. 22, Iss. 3, 2018-03 ,pp. : 1894-1908

John Wiley & Sons Inc

Access to resources Recommend Favorite

A novel biphenyl urea derivate inhibits the invasion of breast cancer through the modulation of CXCR4

By  

Journal of Cellular and Molecular Medicine, Vol. 19, Iss. 7, 2015-07 ,pp. : 1614-1623

John Wiley & Sons Inc

Access to resources Recommend Favorite

The 3p14.2 tumour suppressor ADAMTS9 is inactivated by promoter CpG methylation and inhibits tumour cell growth in breast cancer

By  

Journal of Cellular and Molecular Medicine, Vol. 22, Iss. 2, 2018-02 ,pp. : 1257-1271

John Wiley & Sons Inc

Access to resources Recommend Favorite

miR‐134 inhibits non‐small cell lung cancer growth by targeting the epidermal growth factor receptor

By  

Journal of Cellular and Molecular Medicine, Vol. 20, Iss. 10, 2016-10 ,pp. : 1974-1983

John Wiley & Sons Inc

Access to resources Recommend Favorite

Aurantiamide acetate suppresses the growth of malignant gliomas in vitro and in vivo by inhibiting autophagic flux

By  

Journal of Cellular and Molecular Medicine, Vol. 19, Iss. 5, 2015-05 ,pp. : 1055-1064

John Wiley & Sons Inc

Access to resources Recommend Favorite